HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

Plant Based Pharmaceuticals

Plant Based Pharmaceuticals

Plant-based pharmaceuticals, also known as phytomedicines or phytopharmaceuticals, represent a burgeoning field at the intersection of traditional herbal medicine and modern pharmaceuticals. These medicines are derived from botanical sources, harnessing the therapeutic properties of various plant compounds to prevent, treat, or manage diseases. With a rich history spanning centuries across diverse cultures, plant-based pharmaceuticals offer a treasure trove of bioactive compounds, including alkaloids, flavonoids, terpenoids, and polyphenols, which exhibit a wide array of pharmacological effects. Advancements in technology, such as extraction techniques, bioassay-guided fractionation, and phytochemical profiling, have facilitated the identification, isolation, and standardization of these active compounds, enhancing their efficacy and safety profiles. From aspirin derived from willow bark to the cancer-fighting properties of the Madagascar periwinkle, numerous plant-derived drugs have made significant contributions to modern medicine. Moreover, the growing demand for natural and sustainable healthcare options, coupled with concerns regarding synthetic drug side effects and environmental impact, has fueled the resurgence of interest in plant-based therapies. This resurgence is evident in the development of novel plant-derived drugs for various ailments, including cardiovascular diseases, cancer, diabetes, neurodegenerative disorders, and infectious diseases. Additionally, botanical supplements and nutraceuticals, ranging from turmeric extracts to ginseng capsules, have gained popularity as adjunctive therapies for promoting general health and well-being. However, challenges such as standardization, quality control, bioavailability, and regulatory frameworks persist in the development and commercialization of plant-based pharmaceuticals. Despite these challenges, the integration of traditional herbal knowledge with modern scientific methodologies holds immense promise for the discovery and development of safer, more effective, and sustainable therapeutic interventions, ushering in a new era of plant-powered medicine.

Committee Members
Speaker at Plant Biology and Biotechnology 2025 - Mohammad Babadoost

Mohammad Babadoost

University of Illinois, United States
Speaker at Plant Biology and Biotechnology 2025 - Edward Curry Owner

Edward Curry Owner

Curry Farms, United States
Speaker at Plant Biology and Biotechnology 2025 - Mary Cole

Mary Cole

The University of Melbourne, Australia
GPB 2025 Speakers
Speaker at Plant Biology and Biotechnology 2025 - Vasilia A Fasoula
Vasilia A Fasoula
Adjunct Research Scientist and Consultant, United States
Speaker at Plant Biology and Biotechnology 2025 - Edgar Omar Rueda Puente
Edgar Omar Rueda Puente
Universidad de Sonora, Mexico
Speaker at Plant Biology and Biotechnology 2025 - Bijayalaxmi Mohanty
Bijayalaxmi Mohanty
National University of Singapore, Singapore
Speaker at Plant Biology and Biotechnology 2025 - Rameshkumar K B
Rameshkumar K B
Jawaharlal Nehru Tropical Botanic Garden and Research Institute, India
Tags

Submit your abstract Today

Signup for updates

By submitting this form, you are consenting to receive emails and notifications from Magnus Group. You can revoke your consent to receive emails at any time by using the Safe Unsubscribe link, found at the bottom of every email

Watsapp